Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  cholecalciferol
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-25 of 25 for your search:
Start Over
Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: s55283, 2013-001064-27, NCT01809171
Study of Folic Acid, Calcium and Vitamin D in Preventing Colorectal Polyps and Colorectal Cancer
Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 50 to 80
Sponsor: Other
Protocol IDs: SQ2011SF12RJ, SQ2011SF12-20121010, NCT02066688
Study of Calcium Plus Vitamin D Supplementation in Prevention of Colorectal Adenomas Recurrence
Phase: Phase III, Phase II
Type: Prevention
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2014BAI09B05, NCT02143505
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 128308, NCI-2009-01530, P30CA016056, RPCI-I-128308, NCT00887432
MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: S480/209, 2009-012049-46, NCT01264874
Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: VITACAL, VA 2010/12, 2010-023459-27, NCT01480869
The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases
Phase: Phase III
Type: Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: D-HEM, NCT01518959
The International Polycap Study 3 (TIPS-3)
Phase: Phase III
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: Other
Protocol IDs: TIPS-3, NCT01646437
Vitamin D Supplementation in Cutaneous Malignant Melanoma Outcome
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2012LRDVDCM, 2012-002125-30, NCT01748448
Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Vitamin D3/377/TMH, TMH project No. 377, NCT01608451
Vitamin D for Treatment of Glioblastoma Multiforme
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SOR504110CTIL, NCT01181193
Changes in Breast Cancer Biomarkers Using Synergistic Prostaglandin Inhibitors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 200806, NCT01425476
Changes in Biomarkers Using Prostaglandin Inhibitors
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 200807-001, NCT01769625
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance
Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792
Vitamin D and Physical Activity on Bone Health
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 88
Sponsor: Other
Protocol IDs: 34834, NCT01419730
Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 19 to 90
Sponsor: Other
Protocol IDs: CLIN-007-12S, Pro00019745, NCT01759771
Effects of Vitamin D in Patients With Breast Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 20120362-2OH, NCT01948128
Vitamin D Supplementation for Adults With Neurofibromatosis Type 1 (NF1)
Phase: Phase II
Type: Prevention
Status: Approved-not yet active
Age: 25 to 40
Sponsor: Other
Protocol IDs: DoD A-17236, W18XWH-12-1-0487, NCT01968590
High-dose Vitamin D Supplementation for ADT-induced Side Effects
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: 1R21CA175793-01A1, NCT02064946
Curcumin and Cholecalciferol in Treating Patients With Previously Untreated Stage 0-II Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CASE5913, NCI-2014-00266, P30CA043703, NCT02100423
Deferasirox, Cholecalciferol, and Azacitidine in the Treatment of Newly Diagnosed AML Patients Over 65
Phase: Phase II
Type: Treatment
Status: Active
Age: 65 and over
Sponsor: Other
Protocol IDs: 204961, NCT02341495
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 206519, NCT02186015
Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: LS1293, NCI-2013-00037, Mod12-007862-13, P30CA015083, NCT01787409
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Decreased Bone Mineral Density
Phase: No phase specified
Type: Supportive care
Status: Approved-not yet active
Age: Not specified
Sponsor: Other
Protocol IDs: SanghaiXinhua, NCT02304757
Start Over